People: Acorda Therapeutics Inc (ACOR.O)

ACOR.O on Nasdaq

32.73USD
28 Aug 2015
Change (% chg)

$1.04 (+3.28%)
Prev Close
$31.69
Open
$31.64
Day's High
$32.79
Day's Low
$31.64
Volume
1,074,544
Avg. Vol
625,058
52-wk High
$45.45
52-wk Low
$27.92

Search Stocks

Rogers, Michael 

Mr. Michael W. Rogers is a Chief Financial Officer of Acorda Therapeutics, Inc. Mr. Rogers joins Acorda with 22 years of experience in the biopharmaceutical industry. Most recently, he served as Executive Vice President and CFO of BG Medicine, Inc., where he led the company's successful initial public offering (IPO) in 2011 and was instrumental in assisting in the launch of that company's first product in the cardiovascular area. Prior to that, Mr. Rogers served as the CFO of Indevus Pharmaceuticals for 10 years until the company's sale to Endo Pharmaceuticals. He has led multiple private and public financings and had a central role in numerous mergers and acquisitions over the course of his career, which includes both in-house leadership positions and serving as an external financial advisor.

Basic Compensation

Total Annual Compensation, USD 649,584
Restricted Stock Awards, USD 72,262
Long-Term Incentive Plans, USD --
All Other, USD 573,220
Fiscal Year Total, USD 1,295,070

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Ron Cohen

4,045,180

Michael Rogers

1,295,070

Andrew Blight

1,484,560

Jane Wasman

2,334,280

Enrique Carrazana

1,663,700

Andrew Hindman

5,167,670
As Of  30 Dec 2014
Search Stocks